Literature DB >> 33411142

Characteristics and phenotype heterogeneity in late-onset Behçet's syndrome: a cohort from a referral center in China.

Jun Zou1, Dan Luo1, Yan Shen1, Jian-Long Guan2.   

Abstract

OBJECTIVES: To evaluate the demographics, clinical aspects, and major organ involvement of patients with late-onset Behçet's syndrome (BS) in a tertiary center in China.
METHODS: We conducted a cross-sectional study of consecutive BS patients in Huadong Hospital of Fudan University from September 2012 to January 2020. We compared clinical variables between patients with disease onset before and after 40 years of age. The relative risks (RRs) of clinical variables were calculated between the two age groups. Moreover, a hierarchical cluster analysis was conducted according to 29 variables to determine homogeneous subgroups in patients with late-onset BS.
RESULTS: We enrolled 152 late-onset BS patients, with a median age at onset of 47 years (interquartile range, IQR: 43-52 years). There is a higher prevalence of intestinal ulcers in late-onset BS than in early-onset BS (RR 1.47), but a lower prevalence of ocular involvements (RR 0.54) and folliculitis (RR 0.46). Female sex was associated with genital ulcers, erythema nodosum, and arthritis. Four clusters (C1-C4) were formed. C1 (n = 71), the largest cluster, was defined as the mucocutaneous group, C2 (n = 20) as the arthritis group, C3 (n = 39) as the gastrointestinal group, in which all patients presented with intestinal lesions, and five cases with esophageal ulcers. In C4 (n = 22), showing a mixture of uveitis and vascular lesions, 15 patients presented with uveitis and 8 had vascular lesions, and 1 case had central nervous system lesions.
CONCLUSION: Four phenotype clusters were identified. Patients with skin lesions comprised the largest cluster, while gastrointestinal, panuveitis, and cardiovascular clusters are the most commonly involved organs in late-onset BS patients. Key Points • Our analysis demonstrated the phenotype discrepancy between early and late onset groups. • Four phenotype clusters were identified, with gastrointestinal, panuveitis and cardiovascular clusters representing commonly involved organs.

Entities:  

Keywords:  Behçet’s syndrome; Clinical manifestation; Cluster analysis; Late onset; Major organ involvement; Phenotype

Mesh:

Year:  2021        PMID: 33411142     DOI: 10.1007/s10067-020-05536-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Comparison of clinical features of Behcet disease according to age in a Tunisian cohort.

Authors:  Amira Hamzaoui; Fatima Jaziri; Thouraya Ben Salem; Fatma Said Imed Ben Ghorbel; Mounir Lamloum; Monia Smiti Khanfir; Habib Houman Mohamed
Journal:  Acta Med Iran       Date:  2014

2.  Prevalence of Behçet's disease in rural western Turkey: a preliminary report.

Authors:  N Cakir; E Dervis; O Benian; O N Pamuk; N Sonmezates; R Rahimoglu; S Tuna; T Cetin; Y Sarikaya
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

3.  Activation of neutrophils by testosterone in Behçet's disease.

Authors:  S Yavuz; G Ozilhan; Y Elbir; A Tolunay; E Eksioglu-Demiralp; H Direskeneli
Journal:  Clin Exp Rheumatol       Date:  2007 Jul-Aug       Impact factor: 4.473

Review 4.  Recent research into Behçet's disease in Japan.

Authors:  Y Mizushima
Journal:  Int J Tissue React       Date:  1988

5.  The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.

Authors:  Berivan Bitik; Abdurrahman Tufan; Kubilay Sahin; Yesim Sucullu Karadag; Sevinc Can Sandikci; Ridvan Mercan; Fikri Ak; Yasar Karaaslan; Mehmet Akif Ozturk; Berna Goker; Seminur Haznedaroglu
Journal:  Clin Exp Rheumatol       Date:  2016-10-07       Impact factor: 4.473

6.  [Some special clinical manifestations of Behcet's disease---report of illustrative cases and review of literature (author's transl)].

Authors:  S P Chen
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1980-01

7.  Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity.

Authors:  I Krause; R Mader; J Sulkes; M Paul; Y Uziel; M Adawi; A Weinberger
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.